HIGHLIGHTS
- who: Stefano Fortinguerra and collaborators from the Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy have published the paper: Pharmacogenomic Characterization in Bipolar Spectrum Disorders, in the Journal: (JOURNAL)
- what: The authors report the pharmacogenomics state of the art in bipolar disorders and suggest an algorithm for therapeutic regimen choice.
SUMMARY
Patients with the CC genotype and schizophrenia who are treated with clozapine may have a decreased response to clozapine as compared to patients with the CT or TT genotype. lithium Patients with the CC genotype and bipolar . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.